On Monday, Moderna announced its COVID-19 vaccine generates a strong antibody response in children ages six to eleven. This comes as the University of Wisconsin School of Medicine is conducting the state’s first ever pediatric COVID-19 vaccine study for Moderna.
Office of Strategic Communication